IP Library Granted Patent US 10,060,909
Granted Patent B2
US 10,060,909 · App. 14/509,761 · Granted Aug 28, 2018

Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof

Inventors: Catherine Tachdjian (San Diego, CA); Andrew P. Patron (San Marcos, CA); Sara L. Adamski-Werner (San Diego, CA); Farid Bakir (San Diego, CA); Qing Chen (San Diego, CA); Vincent Darmohusodo (Encinitas, CA); Stephen Terrence Hobson (San Marcos, CA); Xiaodong Li (San Diego, CA); Ming Qi (Shanghai, CN); Daniel H. Rogers (San Diego, CA); Marketa Rinnova (San Diego, CA); Guy Servant (San Diego, CA); Xiao-Qing Tang (San Diego, CA); Mark Zoller (La Jolla, CA); David Wallace (San Diego, CA); Amy Xing (San Diego, CA); Klaus Gubernator (Del Mar, CA)
Assignee: Senomyx, Inc.
G01N33/543A23L2/56A23L27/202A23L27/203A23L27/2054A23L27/88A61K8/4973A61K8/55A61K47/22A61K47/24C07C233/65C07C235/54C07C275/30C07C275/34C07D307/84C07D317/68C07D405/12C07F9/65517G01N33/5041G01N33/566G01N33/74A23V2002/00G01N2333/726
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,060,909
App. No.
14/509,761
Granted
Aug 28, 2018
Kind
B2
Abstract

The present invention relates to the discovery that certain non-naturally occurring, non-peptide amide compounds and amide derivatives, such as oxalamides, ureas, and acrylamides, are useful flavor or taste modifiers, such as a flavoring or flavoring agents and flavor or taste enhancer, more particularly, savory (the “umami” taste of monosodium glutamate) or sweet taste modifiers,—savory or sweet flavoring agents and savory or sweet flavor enhancers, for food, beverages, and other comestible or orally administered medicinal products or compositions.

Claims (183)

1. An amide compound having the following formula:

or a comestibly acceptable salt thereof; wherein

A is phenyl;

m is 1 or 2;

each R 1′ is independently selected from alkyl, alkoxy, alkoxy-alkyl, hydroxyalkyl, CN, CO 2 H, CO 2 R 6 , CHO, COR 6 , SR 6 , fluoro, chloro, cycloalkyl, cycloalkenyl, heterocycle, aryl, haloalkoxy, and heteroaryl;

R 6 is C 1 -C 6 alkyl;

i) R 2 is a C 3 -C 10 branched alkyl or cycloalkyl optionally substituted with one to four substituents each independently selected from alkoxy, alkoxy-alkyl, hydroxyalkyl, OH, NH 2 , NHR 6 , N(R 6 ) 2 , CN, CO 2 H, CO 2 R 6 , CHO, COR 6 , SH, SR 6 , halogen, alkenyl, cycloalkyl, cycloalkenyl, aryl, haloalkyl, haloalkoxy, and heteroaryl; and R 6 is C 1 -C 6 alkyl; or

ii) R 2 is a 1-(1,2,3,4) tetrahydronapthalene ring or an 2,3-dihydro-1H-indene ring having the following formula:

wherein n is 1, 2, or 3, and each R 2′ can be bonded to either the aromatic or non-aromatic ring and is independently selected from hydrogen, fluoro, chloro, NH 2 , NHCH 3 , N(CH 3 ) 2 , CO 2 CH 3 , SCH 3 , SEt, methyl, ethyl, isopropyl, vinyl, trifluoromethyl, methoxy, ethoxy, isopropoxy, and trifluoromethoxy groups,

wherein the amide compound has a molecular weight of 500 grams per mole or less.

2. The amide compound of claim 1 , wherein m is 1.

3. The amide compound of claim 1 , wherein m is 2.

4. The amide compound of claim 3 , wherein each R 1′ is independently selected from fluoro, chloro, SCH 3 , SEt, methyl, ethyl, isopropyl, vinyl, methoxy, ethoxy, isopropoxy, and trifluoromethoxy.

5. The amide compound of claim 1 , wherein R 2 is a C 3 -C 10 branched alkyl optionally substituted with one to four substituents independently selected from alkoxy, alkoxy-alkyl, haloalkyl, haloalkoxy, and CO 2 R 6 ; and R 6 is C 1 -C 6 alkyl.

6. The amide compound of claim 5 , wherein R 2 is a C 3 -C 10 branched alkyl optionally substituted with one or two substituents independently selected from hydroxy, fluoro, chloro, CO 2 CH 3 , SCH 3 , SEt, methyl, ethyl, isopropyl, trifluoromethyl, methoxy, ethoxy, isopropoxy, and trifluoromethoxy.

7. The amide compound of claim 1 , wherein R 2 is a cycloalkyl ring having 3 to 10 ring carbon atoms optionally substituted with one to four substituents independently selected from alkyl, alkoxy, alkoxy-alkyl, hydroxyalkyl, haloalkyl, haloalkoxy, and halogen.

8. The amide compound of claim 7 , wherein R 2 is a cycloalkyl ring having 5 to 8 ring carbon atoms optionally substituted with one to four substituents independently selected from methyl, ethyl, isopropyl, trifluoromethyl, methoxy, ethoxy, isopropoxy, and trifluoromethoxy.

9. The amide compound of claim 1 , wherein

A is a phenyl ring;

m is 2;

each R 1′ is independently selected from fluoro, chloro, SCH 3 , SEt, methyl, ethyl, isopropyl, vinyl, methoxy, ethoxy, isopropoxy, and trifluoromethoxy; and

R 2 is a C 3 -C 10 branched alkyl optionally substituted with one or two substituents independently selected from fluoro, chloro, CO 2 CH 3 , SCH 3 , SEt, methyl, ethyl, isopropyl, trifluoromethyl, methoxy, ethoxy, isopropoxy, and trifluoromethoxy; or a cycloalkyl ring having 5 to 8 ring carbon atoms optionally substituted with one to four substituents independently selected from fluoro, chloro, CO 2 CH 3 , SCH 3 , SEt, methyl, ethyl, isopropyl, trifluoromethyl, methoxy, ethoxy, isopropoxy, and trifluoromethoxy.

10. The amide compound of claim 1 , wherein R 2 is a 1-(1,2,3,4)tetrahydronapthalene ring or an 2,3-dihydro-1H-indene ring having the following formula:

wherein each R 2′ can be bonded to either the aromatic or non-aromatic ring and is independently selected from hydrogen, fluoro, chloro, CO 2 CH 3 , SCH 3 , SEt, methyl, ethyl, isopropyl, vinyl, trifluoromethyl, methoxy, ethoxy, isopropoxy, and trifluoromethoxy groups.

11. The amide compound of claim 10 , wherein R 2 has the following formula:

wherein each R 2′ are independently selected from the group consisting of hydrogen, fluoro, chloro, COOCH 3 , SCH 3 , SEt, methyl, ethyl, isopropyl, vinyl, trifluoromethyl, methoxy, ethoxy, isopropoxy, and trifluoromethoxy.

12. An amide compound having the following formula:

or a comestibly acceptable salt thereof; wherein

(R 1′ ) m -A is

wherein m is 1, 2, or 3, and each R 1′ is independently selected from fluoro, chloro, NH 2 , NHCH 3 , N(CH 3 ) 2 , CO 2 CH 3 , SCH 3 , SEt, methyl, ethyl, isopropyl, vinyl, methoxy, ethoxy, isopropoxy, and trifluoromethoxy;

i) R 2 is a C 3 -C 10 branched alkyl or cycloalkyl optionally substituted with one to four substituents each independently selected from alkoxy, alkoxy-alkyl, hydroxyalkyl, NH 2 , NHR 6 , N(R 6 ) 2 , CN, CO 2 H, CO 2 R 6 , CHO, COR 6 , SH, SR 6 , halogen, alkenyl, cycloalkyl, cycloalkenyl, aryl, and heteroaryl and R 6 is C 1 -C 6 alkyl, or

ii) R 2 is a 1-(1,2,3,4) tetrahydronapthalene ring or an 2,3-dihydro-1H-indene ring having the following formula:

wherein n is 1, 2, or 3, and each R 2′ can be bonded to either the aromatic or non-aromatic ring and is independently selected from hydrogen, fluoro, chloro, NH 2 , NHCH 3 , N(CH 3 ) 2 , CO 2 CH 3 , SCH 3 , SEt, methyl, ethyl, isopropyl, vinyl, trifluoromethyl, methoxy, ethoxy, isopropoxy, and trifluoromethoxy groups,

wherein the amide compound has a molecular weight of 500 grams per mole or less.

13. The amide compound of claim 1 , wherein A is phenyl; R 2 is a C 3 -C 10 branched alkyl substituted with one to four substituents each independently selected from alkoxy, alkoxy-alkyl, CO 2 R 6 , COR 6 , and halogen.

14. An amide compound selected from the group consisting of

(R)-methyl 2-(3-chloro-4-methoxybenzamido)-4-methylpentanoate,

4-methoxy-3-methyl-N-(5-methylhexan-3-yl)benzamide,

N-(heptan-4-yl)-2-methylbenzo[d][1,3]dioxole-5-carboxamide,

(S)-methyl 4-methyl-2-(4-methyl-3-(methylthio)benzamido)pentanoate,

4-methoxy-3-methyl-N-(2-methylheptan-4-yl)benzamide,

N-(heptan-4-yl)-6-methylbenzo[d][1,3]dioxole-5-carboxamide,

3,4-dimethyl-N-(2-methylhexan-3-yl)benzamide,

(R)-methyl 4-methyl-2-(5-methylbenzofuran-2-carboxamido)pentanoate,

N-(hexan-3-yl)-4-methoxy-3-methylbenzamide,

N-(heptan-4-yl)-3-methyl-4-(methylthio)benzamide,

N-(hexan-3-yl)-3-methyl-4-(methylthio)benzamide,

methyl 2-(3-chloro-4-methoxybenzamido)hexanoate,

3,4-dimethyl-N-(2-methylheptan-4-yl)benzamide,

N-(hexan-3-yl)-3,4-dimethylbenzamide,

N-(heptan-4-yl)-3,4-dimethylbenzamide,

(R)-methyl 4-methyl-2-(4-(methylthio)benzamido)pentanoate,

4-ethoxy-N-(heptan-4-yl)-3-methylbenzamide,

3,4-dimethyl-N-(5-methylhexan-3-yl)benzamide,

(R)-methyl 4-methyl-2-(4-vinylbenzamido)pentanoate,

4-methoxy-3-methyl-N-(2-methylhexan-3-yl)benzamide,

N-(heptan-4-yl)benzo[d][1,3]dioxole-5-carboxamide,

(R)-methyl 2-(benzo[d][1,3]dioxole-6-carboxamido)-4-methylpentanoate,

(R)-N-(1-methoxy-4-methylpentan-2-yl)-3,4-dimethylbenzamide,

(R)-methyl-2-(2,3-dimethylfuran-5-carboxamido)-4-methylpentanoate,

4-Methoxy-N-(1-methoxymethyl-3-methyl-butyl)-3-methyl-benzamide,

3-chloro-2-hydroxy-N-(2-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

3-chloro-2-hydroxy-N-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

(R)-3-chloro-2-hydroxy-N-(1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

3-chloro-2-hydroxy-N-(5-hydroxy-1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

3-chloro-2-hydroxy-N-(4-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

3-chloro-2-hydroxy-N-(6-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

3-chloro-2-hydroxy-N-(1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

2,3-dihydroxy-N-(2-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

2-hydroxy-N-(2-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

2,3-dihydroxy-N-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

(S)-2,6-dimethyl-N-(1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

N-(5,7-dimethyl-1,2,3,4-tetrahydronaphthalen-1-yl)-3-methylisoxazole-4-carboxamide,

3-methyl-N-(2-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)isoxazole-4-carboxamide,

3-methyl-N-(4-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)isoxazole-4-carboxamide,

N-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)-3-methylisoxazole-4-carboxamide,

(R)-5-bromo-N-(1,2,3,4-tetrahydronaphthalen-1-yl)nicotinamide,

(R)-3-methyl-N-(1,2,3,4-tetrahydronaphthalen-1-yl)isoxazole-4-carboxamide,

(S)-5-bromo-N-(1,2,3,4-tetrahydronaphthalen-1-yl)nicotinamide,

(R)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)furan-3-carboxamide,

(R)-5-methyl-N-(1,2,3,4-tetrahydronaphthalen-1-yl)isoxazole-4-carboxamide,

(R)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)furan-3-carboxamide,

3-methyl-N-(1,2,3,4-tetrahydronaphthalen-l-yl)isoxazole-4-carboxamide,

N-(3,3-dimethylbutan-2-yl)-2,3,5,6-tetrafluoro-4-methylbenzamide,

2,3,5,6-tetrafluoro-4-methyl-N-(3-methylbutan-2-yl)benzamide,

2,3,5,6-tetrafluoro-4-methyl-N-(2-methylcyclohexyl)benzamide,

N-(2-methylcyclohexyl)-3-(trifluoromethoxy)benzamide,

3-chloro-5-fluoro-N-(2-methylcyclohexyl)benzamide,

(R)-N-(3,3-dimethylbutan-2-yl)-2,3,5,6-tetrafluoro-4-methylbenzamide,

4-fluoro-N-(2-methylcyclohexyl)-3-(trifluoromethyl)benzamide,

(S)-2,3,5,6-tetrafluoro-4-methyl-N-(3-methylbutan-2-yl)benzamide,

2,5-dichloro-N-(2-methylcyclohexyl)benzamide,

3,5-dichloro-2,6-dimethoxy-N-(2-methylcyclohexyl)benzamide, and

2,6-dimethyl-N-(2-methylcyclohexyl)benzamide, or a comestibly acceptable salt thereof.

15. An ingestible composition comprising at least a savory flavor modulating amount of at least one compound of claim 1 , or a comestibly acceptable salt thereof.

16. The ingestible composition of claim 15 , wherein the amide compound is present in a concentration from about 0.01 ppm to about 30 ppm.

17. The ingestible composition of claim 15 , wherein the amide compound is present in a concentration from about 0.05 ppm to about 15 ppm.

18. The ingestible composition of claim 15 , wherein the amide compound is present in a concentration from about 0.1 ppm to about 5 ppm.

19. The ingestible composition of claim 15 , wherein the amide compound is present in a concentration from about 0.1 ppm to about 3 ppm.

20. A method for modulating the taste of an ingestible composition comprising:

combining the ingestible composition with at least a savory flavor modulating amount of a compound of claim 1 , or a comestibly acceptable salt thereof, so as to form a taste modified ingestible composition.

21. The method of claim 20 , wherein the amide compound is present in the modified ingestible composition at a concentration from about 0.01 ppm to about 30 ppm.

22. The method of claim 20 , wherein the amide compound is present in the modified ingestible composition in a concentration from about 0.05 ppm to about 15 ppm.

23. The method of claim 20 , wherein the amide compound is present in the modified ingestible composition in a concentration from about 0.1 ppm to about 5 ppm.

24. The method of claim 20 , wherein the amide compound is present in the modified ingestible composition in a concentration from about 0.1 ppm to about 3 ppm.

25. The amide compound of claim 14 , which selected from the group consisting of

(R)-methyl 2-(3-chloro-4-methoxybenzamido)-4-methylpentanoate,

4-methoxy-3-methyl-N-(5-methylhexan-3-yl)benzamide,

N-(heptan-4-yl)-2-methylbenzo[d][1,3]dioxole-5-carboxamide,

(S)-methyl 4-methyl-2-(4-methyl-3-(methylthio)benzamido)pentanoate,

4-methoxy-3-methyl-N-(2-methylheptan-4-yl)benzamide,

N-(heptan-4-yl)-6-methylbenzo[d][1,3]dioxole-5-carboxamide,

3,4-dimethyl-N-(2-methylhexan-3-yl)benzamide,

(R)-methyl 4-methyl-2-(5-methylbenzofuran-2-carboxamido)pentanoate, and

(R)-N-(1-methoxy-4-methylpentan-2-yl)-3,4-dimethylbenzamide, or a comestibly acceptable salt thereof.

26. The amide compound of claim 14 , which selected from the group consisting of

N-(hexan-3-yl)-4-methoxy-3-methylbenzamide,

N-(heptan-4-yl)-3-methyl-4-(methylthio)benzamide,

N-(hexan-3-yl)-3-methyl-4-(methylthio)benzamide,

methyl 2-(3-chloro-4-methoxybenzamido)hexanoate,

3,4-dimethyl-N-(2-methylheptan-4-yl)benzamide,

N-(hexan-3-yl)-3,4-dimethylbenzamide,

N-(heptan-4-yl)-3,4-dimethylbenzamide,

(R)-methyl 4-methyl-2-(4-(methylthio)benzamido)pentanoate,

4-ethoxy-N-(heptan-4-yl)-3-methylbenzamide,

3,4-dimethyl-N-(5-methylhexan-3-yl)benzamide, and

(R)-N-(1-methoxy-4-methylpentan-2-yl)-3,4-dimethylbenzamide, or a comestibly acceptable salt thereof.

27. The amide compound of claim 14 , which selected from the group consisting of

(R)-methyl 4-methyl-2-(4-vinylbenzamido)pentanoate,

4-methoxy-3-methyl-N-(2-methylhexan-3-yl)benzamide,

N-(heptan-4-yl)benzo[d][1,3]dioxole-5-carboxamide,

(R)-methyl 2-(benzo[d][1,3]dioxole-6-carboxamido)-4-methylpentanoate,

(R)-N-(1-methoxy-4-methylpentan-2-yl)-3,4-dimethylbenzamide,

(R)-methyl-2-(2,3-dimethylfuran-5-carboxamido)-4-methylpentanoate, and

4-Methoxy-N-(1-methoxymethyl-3-methyl-butyl)-3-methyl-benzamide, or a comestibly acceptable salt thereof.

28. The amide compound of claim 14 , which selected from the group consisting of

(R)-N-(1-methoxy-4-methylpentan-2-yl)-3,4-dimethylbenzamide,

3-chloro-2-hydroxy-N-(2-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

3-chloro-2-hydroxy-N-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

(R)-3-chloro-2-hydroxy-N-(1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

3-chloro-2-hydroxy-N-(5-hydroxy-1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

3-chloro-2-hydroxy-N-(4-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

3-chloro-2-hydroxy-N-(6-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

3-chloro-2-hydroxy-N-(1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

2,3-dihydroxy-N-(2-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

2-hydroxy-N-(2-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

2,3-dihydroxy-N-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

(S)-2,6-dimethyl-N-(1,2,3,4-tetrahydronaphthalen-1-yl)benzamide,

N-(5,7-dimethyl-1,2,3,4-tetrahydronaphthalen-1-yl)-3-methylisoxazole-4-carboxamide,

3-methyl-N-(2-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)isoxazole-4-carboxamide,

3-methyl-N-(4-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)isoxazole-4-carboxamide,

N-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)-3-methylisoxazole-4-carboxamide,

(R)-5-bromo-N-(1,2,3,4-tetrahydronaphthalen-1-yl)nicotinamide,

(R)-3-methyl-N-(1,2,3,4-tetrahydronaphthalen-1-yl)isoxazole-4-carboxamide,

(S)-5-bromo-N-(1,2,3,4-tetrahydronaphthalen-1-yl)nicotinamide,

(R)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)furan-3-carboxamide,

(R)-5-methyl-N-(1,2,3,4-tetrahydronaphthalen-1-yl)isoxazole-4-carboxamide,

(R)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)furan-3-carboxamide, and

3-methyl-N-(1,2,3,4-tetrahydronaphthalen-1-yl)isoxazole-4-carboxamide, or a comestibly acceptable salt thereof.

29. The amide compound of claim 14 , which selected from the group consisting of

(R)-N-(1-methoxy-4-methylpentan-2-yl)-3,4-dimethylbenzamide,

N-(3,3-dimethylbutan-2-yl)-2,3,5,6-tetrafluoro-4-methylbenzamide,

2,3,5,6-tetrafluoro-4-methyl-N-(3-methylbutan-2-yl)benzamide,

2,3,5,6-tetrafluoro-4-methyl-N-(2-methylcyclohexyl)benzamide,

N-(2-methylcyclohexyl)-3-(trifluoromethoxy)benzamide,

3-chloro-5-fluoro-N-(2-methylcyclohexyl)benzamide,

(R)-N-(3,3-dimethylbutan-2-yl)-2,3,5,6-tetrafluoro-4-methylbenzamide,

4-fluoro-N-(2-methylcyclohexyl)-3-(trifluoromethyl)benzamide,

(S)-2,3,5,6-tetrafluoro-4-methyl-N-(3-methylbutan-2-yl)benzamide,

2,5-dichloro-N-(2-methylcyclohexyl)benzamide,

3,5-dichloro-2,6-dimethoxy-N-(2-methylcyclohexyl)benzamide, and

2,6-dimethyl-N-(2-methylcyclohexyl)benzamide, or a comestibly acceptable salt thereof.

30. The amide compound of claim 14 , which selected from the group consisting of

(R)-methyl 2-(3-chloro-4-methoxybenzamido)-4-methylpentanoate,

(S)-methyl 4-methyl-2-(4-methyl-3-(methylthio)benzamido)pentanoate,

(R)-methyl 4-methyl-2-(5-methylbenzofuran-2-carboxamido)pentanoate,

methyl 2-(3-chloro-4-methoxybenzamido)hexanoate,

(R)-methyl 4-methyl-2-(4-(methylthio)benzamido)pentanoate,

(R)-methyl 4-methyl-2-(4-vinylbenzamido)pentanoate,

(R)-N-(1-methoxy-4-methylpentan-2-yl)-3,4-dimethylbenzamide,

(R)-methyl-2-(2,3-dimethylfuran-5-carboxamido)-4-methylpentanoate,

4-Methoxy-N-(1-methoxymethyl-3-methyl-butyl)-3-methyl-benzamide, or a comestibly acceptable salt thereof.

31. The amide compound of claim 14 , wherein the compound is (R)-N-(1-methoxy-4-methylpentan-2-yl)-3,4-dimethylbenzamide, or a comestibly acceptable salt thereof.

Assignments (3)
MERGER Recorded Nov 5, 2021
From: SENOMYX, INC.
To: FIRMENICH INCORPORATED
Reel/Frame 058037/0260 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2014
From: TACHDJIAN, CATHERINE; PATRON, ANDREW P.; ADAMSKI-WERNER, SARA L.; BAKIR, FARID; CHEN, QING; DARMOHUSODO, VINCENT; HOBSON, STEPHEN TERRENCE; LI, XIAODONG; QI, MING; RINNOVA, MARKETA; SERVANT, GUY; TANG, XIAO-QING; ZOLLER, MARK; WALLACE, DAVID; XING, AMY; GUBERNATOR, KLAUS
To: SENOMYX, INC.
Reel/Frame 033957/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2014
From: ROGERS, DANIEL H.
To: SENOMYX, INC.
Reel/Frame 034200/0439 →
Continuity (6)
Division 13336272 · Dec 23, 2011
Division 12257017 · Oct 23, 2008
Division 10913303 · Aug 6, 2004
Provisional Application 60552064 · Mar 9, 2004
Provisional Application 60494071 · Aug 6, 2003
Related Publication 20150093339A1 · Apr 2, 2015